Alpiropride
Alpiropride[edit]
Alpiropride is a pharmaceutical compound that belongs to the class of atypical antipsychotics. It is primarily used in the treatment of schizophrenia and other disorders characterized by psychosis. Alpiropride functions as a dopamine receptor antagonist, which helps in modulating the effects of dopamine in the brain, thereby alleviating symptoms of psychosis.
Pharmacology[edit]
Alpiropride acts on the central nervous system by selectively blocking dopamine D2 receptors. This action reduces the overactivity of dopamine pathways that are often implicated in psychotic disorders. Unlike typical antipsychotics, alpiropride has a lower affinity for serotonin receptors, which contributes to its atypical profile and potentially fewer side effects related to movement disorders.
Clinical Use[edit]
Alpiropride is indicated for the management of schizophrenia, particularly in patients who do not respond adequately to other antipsychotic medications. It may also be used off-label for other conditions as determined by a healthcare provider. The drug is administered orally, and the dosage is adjusted based on the patient's response and tolerance.
Side Effects[edit]
Common side effects of alpiropride include drowsiness, weight gain, and dry mouth. More serious side effects can include extrapyramidal symptoms, although these are less common compared to typical antipsychotics. Patients should be monitored for signs of tardive dyskinesia and neuroleptic malignant syndrome, which are rare but serious conditions associated with antipsychotic use.
Mechanism of Action[edit]
Alpiropride's primary mechanism involves the antagonism of dopamine D2 receptors in the brain. This action helps to balance the neurotransmitter activity, which is often disrupted in psychotic disorders. The drug's atypical nature is attributed to its selective receptor profile, which minimizes the risk of certain side effects commonly seen with older antipsychotic drugs.
History and Development[edit]
Alpiropride was developed as part of a new generation of antipsychotic medications aimed at improving the safety and efficacy profile compared to earlier treatments. Its development focused on reducing the incidence of side effects such as akathisia and dystonia, which are often associated with traditional antipsychotics.
Related pages[edit]
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
